Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
Why do we sometimes underperform when it matters most? Hidden mental interference can hijack attention. How do we regain ...
The study, published in Genomic Psychiatry, identified how stress hormones activate specific RNA molecules called long ...
The origin of life from Earth's primordial chemistry has long fascinated and perplexed us. Generations of scientists have endeavored to understand how complex biochemistry developed from organic ...
Nicole Steinmetz engineers plant virus nanoparticles into versatile drug-delivery platforms. This work expanded into cancer ...
Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...
The Fiesta Bowl matchup between No. 6 Mississippi and No. 10 Miami turned into an instant classic, with the Hurricanes coming from behind to win 31-27 and advance to the College Football Playoff ...
The NBC officiating analyst had the same reaction that just about everybody else did when no flag was thrown on a seemingly blatant pass interference call in the fourth quarter. Drake Maye’s deep ball ...
Research into how a father’s choices — such as diet, exercise, stress, nicotine use — may transfer traits to his children has become impossible to ignore. The standard sperm-meets-egg story posits ...
With six drugs approved for commercial development, Cambridge-based drugmaker Alnylam Pharmaceuticals Inc. is investing $250 million into its biomanufacturing plant in Norton. The expansion comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results